
infant product Recalls
794 recalls tagged with “infant product”.

Connecticut Crab Company Crab Cakes Recalled for Temperature Abuse Risk, 39 Boxes Affected
May be temperature abused, which may result in growth of Clostridium botulinum
Omnipaque Injection Recalled by GE Healthcare for Particulate Matter in 866,570 vials (2026)
GE Healthcare Omnipaque Iohexol Injection Recall Expanded for Particulate Matter in 306,810 Vials (D
Fagron Compounding Services Vancomycin HCI Recall: 34,260 Bags with Break-Off-Part Risk (2026)
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Fagron Compounding Services Vancomycin HCl 1 g in 250 mL NS Injection Recall Expands in 2026
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Fagron Compounding Services Norepinephrine Bitartrate Injection Recall Affects 5,140 Bags (2026)
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Clonidine Transdermal System Recall Expanded for CGMP Deviations in 113,943 Cartons (2026)
Teva-affiliated Clonidine Transdermal System recalls 113,943 cartons after CGMP deviations. Unapproved raw material prompts recall. Stop use immediately and contact Teva or a healthcare provider for guidance.

Wagner Spray Tech Recalls 900-Series Power Steamers Over Burn Hazard (2026)


Electrolux Group Recalls Frigidaire Gas Ranges for Burn Hazard (2026)

Tainoki Fine Furniture Recalls 3 Office Chairs Over Fall Hazard (2026)

Lifetime Brands Recalls BUILT LUUM Light Up Tumblers for Choking and Battery Ingestion Hazards (2026
Teva Octreotide Acetate Injectable Suspension Recall 21,930 Cartons Over Sterility Risk (2026)
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Curosurf 240 mg Poractant Alfa Recalled for Sterility Concerns (2026)
Chiesi USA recalled 7,235 Curosurf vials distributed nationwide to hospitals and clinics. The recall cites a lack of assurance of sterility. Healthcare providers should stop using the product immediately and contact Chiesi USA for guidance.
Teva Octreotide Acetate Injectable Suspension Recall 19,869 Cartons Nationwide (2026)
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Xanax XR Alprazolam Recall Over Failed Dissolution Specifications Affects US Nationwide Distribution
Cipla USA Lanreotide Injection Recall for Sterility Assurance Issue (2026)
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
Pure Vitamins and Natural Supplements Blue Bull Extreme Recall for undeclared sildenafil (High risk)
FDA analysis revealed the presence of undeclared sildenafil
Lanreotide Injection recall: Cipla USA lanreotide acetate pre-filled syringes recalled for sterility
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.